中文
| Catalogue |
|
|
| Recommend Products |
MIMETAS BV
Netherlands, Manufacturer, Hits: 549, Updated:5/7/2022
Leiden, the Netherlands |
Company Profile
-
MIMETAS (Leiden, The Netherlands) is a global leader in disease modeling using organ-on-a-chip technologies. Its proprietary OrganoPlate? platform enables developing and high-throughput screening of physiologically relevant disease models for drug discovery and development. The company offers its technology and know-how in therapy co-development projects, services, and off-the-shelf products. MIMETAS works with leading pharmaceutical and biotech companies worldwide to develop novel therapies against unsolved diseases. MIMETAS was founded in 2013 in Leiden, the Netherlands, and has grown into a multinational company with operations in Europe, Asia, and the USA.
To learn more about MIMETAS' disease modeling capabilities and its OrganoPlate? platform, visit www.mimetas.com
Company News
- MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model A... 11/29/2023
- MIMETAS and Astellas Expand Partnership to Include Automation and Application Support 6/20/2023
- MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology 3/29/2023
- MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules 3/9/2023
- MIMETAS Expands Adult Stem Cell Organoid License to All Organs 5/7/2022